NCT03834766View on ClinicalTrials.gov

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

February 6, 2019

Primary Completion Date

October 19, 2019

Study Completion Date

October 19, 2019

Conditions
ADHD
Interventions
DRUG

AMPH ER Tab 5, 10, 15 and 20 mg

Amphetamine

DRUG

AMPH ER Tab Matching Placebo 5, 10, 15 and 20 mg

Placebo

Trial Locations (3)

32751

Meridien Research, Inc., Maitland

89128

Center for Psychiatry and Behavioral Medicine, Las Vegas

344201

Meridien Research, Bradenton

Sponsors
All Listed Sponsors
collaborator

Premier Research Group plc

UNKNOWN

lead

Tris Pharma, Inc.

INDUSTRY

NCT03834766 - Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD | Biotech Hunter | Biotech Hunter